Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-17

Clinical Trial Update: Effect of Food on Opicapone [Phase 1]

View source ↗

Summary

A Phase 1 study evaluated the effect of food on the pharmacokinetics of opicapone in Parkinson disease and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OpiCapone

Snippet

Sponsor: Bial - Portela C S.A. | Conditions: Parkinson Disease | Phase 1 | Status: COMPLETED